Clinical Trials Logo

Adnexal Mass clinical trials

View clinical trials related to Adnexal Mass.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05974618 Recruiting - Pregnancy Related Clinical Trials

Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)

pIOTA
Start date: June 5, 2023
Phase:
Study type: Observational [Patient Registry]

Prospective Validation of the ADNEX Model for discrimination between benign and malignant adnexal masses in pregnancy: International Ovarian Tumour Analysis in pregnancy study (p-IOTA)

NCT ID: NCT05842629 Recruiting - Ovarian Cancer Clinical Trials

Improved Diagnosis of Ovarian Cancer

Start date: May 15, 2021
Phase:
Study type: Observational

After implementation of systematic image description of adnexal masses, we aim to improve and evaluate our use of available imaging methods and biomarkers for classifying adnexal masses and distinguishing between benign and malignant adnexal masses in the hands of clinicians in Central Denmark Region. Secondarily, we want to improve our management of adnexal masses by evaluating the complications and longitudinal changes in conservatively managed adnexal masses. Data is registered prospectively but analyzed retrospectively.

NCT ID: NCT05815992 Recruiting - Adnexal Mass Clinical Trials

Accuracy of the Characterization of Adnexal Masses, Indeterminate at Ultrasonography, Using a MRI Protocol Without Contrast: Validation of the Cambridge Score

CAMBRIDGE
Start date: September 1, 2021
Phase:
Study type: Observational

The aim of this prospective observational study is to evaluate the accuracy and to validate the Cambridge Score,a Test Index to predict the malignancy of the ovarian lesions on the basis of an MRI examination without contrast

NCT ID: NCT05461872 Recruiting - Adnexal Mass Clinical Trials

Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES

Start date: August 12, 2022
Phase:
Study type: Observational

To review the characteristic, presentation and outcome of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

NCT ID: NCT05051722 Recruiting - Ovarian Cancer Clinical Trials

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

ECHO
Start date: August 3, 2021
Phase:
Study type: Observational

The overarching objective of this project is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) cancer-specific methylated DNA markers and high-risk human papilloma virus (HR-HPV) detected in vaginal fluid and/or plasma. This proposal defines Phase II MDM-based cancer detection studies in endometrial cancer (EC) and endometrial hyperplasia with atypia (AEH) in tampon-collected vaginal fluid and 2) ovarian cancer (OC) in plasma and tampon-collected vaginal fluid. Additionally, it defines necessary Phase I MDM-based cancer detection and exploratory aims to test novel cervical cancer (CC) MDMs and test the specificity of cancer-specific MDMs among various common benign gynecologic pathologies.er detection and exploratory aims to test novel cervical cancer MDMs and test the specificity of cancer-specific MDMs among various common benign gynecologic pathologies.

NCT ID: NCT05017246 Recruiting - Fibroid Uterus Clinical Trials

Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy

Start date: January 18, 2022
Phase: Phase 2
Study type: Interventional

To determine if opioid consumption postoperatively among patients undergoing non-emergent laparotomy by the gynecologic oncology service who receive intrathecal morphine with intraoperative lidocaine (IML) infusion are lower than patients who have epidural anesthesia with PCA (EPCA).